eClinical Tech News

Nanobiotix has closed a non-dilutive royalty financing with HealthCare Royalty worth up to $71 million, delivering a $50 million...

Novo Nordisk has closed its acquisition of Akero Therapeutics for $54 per share in cash, valuing the deal at...

Japan’s Ministry of Health, Labour and Welfare has approved Dupixent (dupilumab) for children aged 6 to 11 with severe...

FDA has approved two denosumab biosimilars from the Amneal–mAbxience partnership: Boncresa, referencing Prolia for osteoporosis and related uses, and...

Rectify Pharmaceuticals has signed a strategic research and licensing agreement with Boehringer Ingelheim to develop oral small molecules that...

Pluri has expanded its 2024 manufacturing agreement with Remedy Cell, confirming full technology transfer of Remedy Cell’s proprietary, cell-free...

Kamada has secured a two-year extension from Canadian Blood Services to supply four specialty plasma-derived products—WinRho, HepaGam, CytoGam, and...

CAMP4 Therapeutics has entered a research, collaboration, and license agreement with GSK to identify and develop antisense oligonucleotide drug...

Profound Therapeutics, a Flagship Pioneering company focused on discovering proteins within the expanded human proteome, has appointed Tom Chittenden...

Celularity has entered binding term sheets for a $7 million senior secured term loan and up to $5 million...